These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 32006048
21. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH. Brain Res; 2003 Aug 22; 982(1):38-44. PubMed ID: 12915238 [Abstract] [Full Text] [Related]
22. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Negus SS, Mello NK, Linsenmayer DC, Jones RM, Portoghese PS. Psychopharmacology (Berl); 2002 Oct 22; 163(3-4):412-9. PubMed ID: 12373442 [Abstract] [Full Text] [Related]
23. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor. Schattauer SS, Kuhar JR, Song A, Chavkin C. Cell Signal; 2017 Apr 22; 32():59-65. PubMed ID: 28088389 [Abstract] [Full Text] [Related]
24. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice. Sakakihara M, Imamachi N, Saito Y. Reg Anesth Pain Med; 2016 Apr 22; 41(1):69-74. PubMed ID: 26587674 [Abstract] [Full Text] [Related]
25. Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice. Zhou Y, Kreek MJ. Alcohol Clin Exp Res; 2019 Jun 22; 43(6):1077-1090. PubMed ID: 30908671 [Abstract] [Full Text] [Related]
26. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception. Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS. J Pharmacol Exp Ther; 2003 Dec 22; 307(3):1054-64. PubMed ID: 14557380 [Abstract] [Full Text] [Related]
27. Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys. Bowen CA, Negus SS, Zong R, Neumeyer JL, Bidlack JM, Mello NK. Neuropsychopharmacology; 2003 Jun 22; 28(6):1125-39. PubMed ID: 12637953 [Abstract] [Full Text] [Related]
28. Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats. Lazenka ML, Moerke MJ, Townsend EA, Freeman KB, Carroll FI, Negus SS. Psychopharmacology (Berl); 2018 Jan 22; 235(1):203-213. PubMed ID: 29063139 [Abstract] [Full Text] [Related]
29. Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine. Achat-Mendes C, Valdez GR, Platt DM, Rowlett JK, Spealman RD. Psychopharmacology (Berl); 2009 Jun 22; 204(3):489-98. PubMed ID: 19225763 [Abstract] [Full Text] [Related]
30. Nalmefene, a mu opioid receptor antagonist/kappa opioid receptor partial agonist, potentiates cocaine motivation but not intake with extended access self-administration in adult male mice. Windisch KA, Morochnik M, Reed B, Kreek MJ. Neuropharmacology; 2021 Jul 01; 192():108590. PubMed ID: 33974940 [Abstract] [Full Text] [Related]
31. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy. Negus SS, Mello NK. J Pharmacol Exp Ther; 2002 Mar 01; 300(3):1111-21. PubMed ID: 11861822 [Abstract] [Full Text] [Related]
32. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone. Rowlett JK, Wilcox KM, Woolverton WL. J Pharmacol Exp Ther; 1998 Jul 01; 286(1):61-9. PubMed ID: 9655842 [Abstract] [Full Text] [Related]
33. Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A. Inan S, Lee DY, Liu-Chen LY, Cowan A. Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar 01; 379(3):263-70. PubMed ID: 18925386 [Abstract] [Full Text] [Related]
34. Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. Mello NK, Negus SS. J Pharmacol Exp Ther; 1998 Aug 01; 286(2):812-24. PubMed ID: 9694938 [Abstract] [Full Text] [Related]
35. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition. Abraham AD, Fontaine HM, Song AJ, Andrews MM, Baird MA, Kieffer BL, Land BB, Chavkin C. Neuropsychopharmacology; 2018 Jan 01; 43(2):362-372. PubMed ID: 28649993 [Abstract] [Full Text] [Related]
36. Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Woodlief K, Allen MI, Cornelissen JC, Banks ML, Newman AH, Nader MA. Neuropsychopharmacology; 2023 Nov 01; 48(12):1716-1723. PubMed ID: 37118057 [Abstract] [Full Text] [Related]
37. Effects of kappa opioid agonists on the discriminative stimulus effects of cocaine in rhesus monkeys. Negus SS, Mello NK. Exp Clin Psychopharmacol; 1999 Nov 01; 7(4):307-17. PubMed ID: 10609965 [Abstract] [Full Text] [Related]
38. Effects of Selective and Mixed-Action Kappa and Delta Opioid Receptor Agonists on Pain-Related Behavioral Depression in Mice. Negus SS, St Onge CM, Lee YK, Li M, Rice KC, Zhang Y. Molecules; 2024 Jul 16; 29(14):. PubMed ID: 39064909 [Abstract] [Full Text] [Related]
39. Role of mu-opioid agonist efficacy on antinociceptive interactions between mu agonists and the nociceptin opioid peptide agonist Ro 64-6198 in rhesus monkeys. Cornelissen JC, Steele FF, Tenney RD, Obeng S, Rice KC, Zhang Y, Banks ML. Eur J Pharmacol; 2019 Feb 05; 844():175-182. PubMed ID: 30552903 [Abstract] [Full Text] [Related]
40. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. Valdez GR, Platt DM, Rowlett JK, Rüedi-Bettschen D, Spealman RD. J Pharmacol Exp Ther; 2007 Nov 05; 323(2):525-33. PubMed ID: 17702903 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]